Highlights Alvotech Nyse

Equities

ALVO

LU2458332611

Real-time Estimate Cboe BZX Other stock markets 08:29:29 15/05/2024 pm IST			5-day change	1st Jan Change
13.34 ^USD	-0.11%		-3.68%	+42.75%

30/04	Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals	MT
30/04	Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals	30/04	MT
Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent	30/04	MT
Alvotech Announces U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira	30/04	CI
Cigna to offer Humira rivals with $0 copay at specialty pharmacy	26/04	RE
Alvotech Announces Topline Results from A Confirmatory Clinical Study for AVT05, A Proposed Biosimilar for Simponi	24/04	CI
Sector Update: Health Care Stocks Advance Late Afternoon	20/04	MT
Sector Update: Health Care Stocks Rise Friday Afternoon	19/04	MT
Sector Update: Health Care	19/04	MT
Alvotech Shares Rise After Signing Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US	19/04	MT
Alvotech Signs Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US	19/04	MT
Alvotech Signs U.S. Agreement to Expand Access for Newly Approved High-Concentration Interchangeable Biosimilar to Humira®	19/04	CI
Alvotech and Teva Announces U.S. FDA Approval of SELARSDI (ustekinumab-aekn), biosimilar to Stelara (ustekinumab)	17/04	CI
Alvotech, Teva Get FDA Approval for Stelara Biosimilar Psoriasis Treatment	17/04	DJ
J&J beats first-quarter profit estimates on cancer drugs strength	16/04	RE
Alvotech Provides Earnings Guidance for the Year 2024 and 2025	21/03	CI
Alvotech Full-Year 2023 Loss Narrows, Revenue Rises	21/03	MT
Alvotech Reports Earnings Results for the Full Year Ended December 31, 2023	21/03	CI
Global markets live: Domino's Pizza, Walt Disney, Broadcom, Ryanair, Exxon Mobil, Goldman Sachs...	26/02
How long will this bullish phase last?	26/02
Alvotech Shares Rise Premarket After Humira Biosimilar Approval	26/02	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Alvotech Nyse

Equities

ALVO

LU2458332611

Highlights

Filters